Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03546686
Title Peri-Operative Ipilimumab+Nivolumab and Cryoablation in Women With Triple-negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Indications

triple-receptor negative breast cancer

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars Sinai Medical Center Recruiting Los Angeles California 90048 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field